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A new development in the management of 
pituitary tumors is the transsphenoidal technique. It 
will be my purpose to show that it provides an elegant 
way of handling the great majority of pituitary 
problems, at least the ones that I have encountered, 
although it has its shortcomings as well as its 
advantages. 
Pituitary tumors manifest themselves in two 
ways-by compressing structures in the neigh-
borhood, primarily the optic nerves and chiasm 
and by the two endocrine manifestations, one being 
the compression of the normal pituitary gland to 
produce varying degrees of hypopituitarism and the 
other, the hyperfunctioning adenoma. A large tumor 
with a suprasellar extension compresses the optic 
chiasm and optic nerves; obviously, a tumor of this 
size would also cause a degree of hypopituitarism. A 
smaller tumor, a microadenoma, can express itself by 
hypersecretion of a hormone before it has either 
produced neighborhood signs or has compressed the 
normal gland to produce hypopituitarism. A func-
tioning microadenoma secretes an excess of a par-
ticular hormone; we have encountered three 
neoplastic cell types that I will describe later. 
We owe the transsphenoidal approach to Harvey 
Cushing, who took up the procedure because at that 
time it was safer than craniotomy. Dr. Cushing, 
working with a headlight (looking very much like a 
coal miner's lamp) and with a simple speculum, 
achieved excellent results. He encountered two 
problems-he was viewing a deep, dark hole without 
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magnification, and there was a CSF lead and 
meningitis without the advantage of antibiotics. A 
Frenchman, Guiot, is largely responsible for rein-
troducing the transsphenoidal procedure. One of his 
brilliant students, Jules Hardy, refined the technique, 
using the operating microscope and an image inten-
sifier, which allows the operator, during the 
procedure, to observe operative maneuvers in the 
region of the sella. 
The anatomical principles underlying the sur-
gical approach to the pituitary are really two: One is 
a sublabial-transnasal-transsphenoidal approach, 
maintaining the strict midline which is of great ad-
vantage to the surgeon, because he can see equally 
well to the right and to the left and he knows that he 
is in the midline. The second is the image intensifier in 
the lateral projection, because this permits the sur-
geon to look on the television monitor so that he can 
approach the sella between the tuberculum and the 
floor; he can see his instruments within the sella, and 
he can put air in the ventricul~r systein at the begin-
ning of the operation and watch the third ventricle 
pulsate down into its normal position as the 
suprasellar component of the tumor is removed. For 
maximum safety, the image intensifier is essential. 
With experience, one can see and identify the normal 
pituitary gland, and the surgeon can be certain that 
the suprasellar component has been removed, 
because the normal intracranial pressure in a semisit-
ting position forces the stretched diaphragm of the 
sella (which we have erroneously referred to as the 
tumor capsule in the past) back down into the sella, 
so that with a sizable suprasellar extension, one ac-
tually ends up with a diaphragm almost pulsating on 
the floor of the sella. 
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Dr. Hardy has recently suggested that mi-
croadenomas of certain cell types occur in pref-
erential sites within the anterior lobe. This has 
not been our experience, but his larger experience is 
more valid. The endocrinologists with their elegant 
techniques can pick up endocrinopathies at an early 
stage. Our neuroradiology had to improve to iden-
tify a microadenoma, when the endocrinopathy was 
defined. This is particularly true, not so much in 
acromegaly, but with the galactorrhea-amenorrhea 
syndrome and postadrenalectomy Nelson's syn-
drome. 
We are completing a paper on our experience 
with the neuroradiology of microadenomas. 
Although in the lateral projection, the sella is un-
remarkable, on plain films, lateral polytome cuts 
show an obviously abnormal sella. With A-P 
polytome cuts, one can predict the location of the 
microadenoma because of depression and thinning of 
the floor of the sella. The surgeon can expose the 
microadenoma at the site of the focal sellar bulging. 
A microadenoma is 1 cm or less in diameter. 
These small tumors are ideally suited to trans-
sphenoidal removal. One would not approach a 
microadenoma with the classical transfrontal tech-
nique, since it is difficult to reach and involves going 
through normal anterior pituitary at an awkward 
angle to reach the adenoma. 
I have removed 60 pituitary tumors by a 
transsphenoidal approach; one-half presented with 
hyperfunctioning adenomas. My experience with 
these tumors has pushed me strongly in two direc-
tions: First, we have an extremely active endocrine 
group and a large number of acromegalic patients; sec-
ond, I work with a neuro-ophthalmologist, William 
F. Hoyt, who attracts patients with unusual eye 
problems, a fair number of whom have pituitary dis-
orders. Approximately one-fourth ~f his patients had 
clinical and chemical hypopituitarism at the time of 
presentation-I I% complained of visual loss; 7%, of 
diplopia; 6%, of headache; and 4% had rhinorrhea . 
Regarding visual-field defects-58% had no de-
fect, 32% had bitemporal hemianopsia or some 
variation of that, and 10% had some other type of 
visual-field defect. 
By routine stains, 62% were chromophobe, 36% 
eosinophil, and 2% basophil. In the chromophobe 
group are some prolactin-secreting adenomas, some 
growth hormone-secreting adenomas, and some 
ACTH-secreting adenomas. According to functional 
types, 40% secreted nothing or, at least, nothing that 
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we recognized. I suspect, however, that this number 
would be smaller, if we checked every patient for 
prolactin levels, because elevated prolactin levels can 
exist without any overt clinical manifestation . The 
remaining 60% secreted an excess of one hormone: 
14% prolactin, 10% ACTH, and the remainder, 
growth hormone. All patients with ACTH-secreting 
tumors had undergone prior adrenalectomy and 
presented with hyper-pigmentation and high ACTH 
levels. 
With respect to anatomical extent of the tumors, 
33% were entirely intrasellar. Some of these were 
microadenomas; some were not. Even with very large 
sellas, the tumor may be contained within the sella. 
The remainder extended beyond the sella-some with 
extrasellar extension in more than one direc-
tion-42% were suprasellar, 28% had eccentric lateral 
extension , and 23% went into the sphenoidal 
sinus. The number of sphenoidal and suprasellar 
extensions is directly related to the quality of the 
neuroradiology. 
When we began using the transsphenoidal 
technique, we got only the castoffs-patients who 
had failed to respond to prior treatment. Ours was 
the second team in terms of handling pituitary 
problems, but as we demonstrated our ability to han-
dle recurrent tumors, we began seeing primary cases. 
As we gain greater experience with the acro-
megalic patients, we are reducing growth hormone 
levels down to very low levels, like 2-3 ng/ml. Not 
a single patient, primarily treated for acromegaly, 
has developed hypopituitarism following opera-
tion. Transsphenoidal removal constitutes excellent 
treatment for acromegaly, and we are seeing more 
and more patients. We are in the process now 
of designing a study which will compare 
transsphenoidal removal alone with transsphenoidal 
removal plus irradiation. Unless postoperative 
growth hormone levels are in the normal range, the 
adenoma has not been removed. Because our ex-
perience is limited, we do not know how many of 
these patients will return with late recurrence. 
Patients with Nelson's syndrome have un-
dergone adrenalectomy for Cushing's disease, and at 
variable times thereafter, become hyperpigmented. 
Many tumors that secrete ACTH are malignant in 
the biologic behavior, which is a compelling reason to 
make the diagnosis and to treat them radically as 
soon as possible. 
One of the more interesting facets of the 
microadenoma story is the syndrome of galac-
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torrhea and amenorrhea. Historically, three 
types of galactorrhea and amenorrhea have 
been described, depending upon whether the syn-
drome appeared following delivery or spontaneously. 
The group of interest here is the Forbes-Albright syn-
drome, which can have its onset either postpartally 
or, more often, spontaneously. By definition, the sella 
turcica is enlarged, and galactorrhea and amenorrhea 
are permanent. The only difference between the 
Forbes-Albright and the Del Castillo syndrome is the 
normal sella, and here I think it is a matter of time. 
These patients have microadenomas, but until one 
studies the sella by polytomography, the sella may 
appear normal. We now have eight of these 
patients-three harbored macroadenomas and the 
remainder, microadenomas. These, like the ACTH-
secreting adenomas, have a greater liability than the 
usual chromophobe adenoma to become invasive. 
For some reason, unlike the growth hormone-
secreting adenomas or acromegaly, tumors that 
secrete prolactin and tumors that secrete ACTH are 
inherently bad actors; that is, they have a relatively 
high risk of becoming malignant as judged by in-
vasive behavior. 
Excluding one patient with an intrasellar 
abscess, we have had no operative deaths, and this is 
a significant advantage of the technique. We di-
vided the morbidity into major and minor, the ma-
jor including pneumonitis and rhinorrhea. If we think 
that the patient might be developing rhinorrhea, we 
treat vigorously in the first five postoperative days; I 
am certain that we are overtreating and unnecessarily 
treating a number of patients. We insert a lumbar 
subarachnoid drain, start Diamox®, and elevate the 
head; and our rhinorrhea rate falls very rapidly. Two 
patients had transient cranial nerve palsies due to 
vigorous use of a curette against the wall of an 
already compressed cavernous sinus. One patient had 
a postoperative hematoma within the tumor capsule. 
This was recognized within four hours, and the 
patient was returned to the operating room, where it 
was removed with no consequences. Five patients 
had diabetes insipidus persisting longer than a month 
and four patients had transient diabetes insipid us. An 
aseptic meningeal reaction from blood in the CSF, 
sinusitis, nose bleed, one corneal abrasion, and 
urinary tract infections represented minor com-
plications. In no patient who had either normal or 
impaired vision prior to operation was vision made 
worse; this makes it a very attractive procedure, 
because even with the very best results from the 
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transfrontal technique, vision was made worse in an 
occasional patient. 
The transsphenoidal technique is the procedure 
of choice under the following circumstances. 
1. Sphenoidal extension; 
2. Modest suprasellar extension without lateral 
extension: We can handle the direct upward 
suprasellar extension. In the last 18 months, I 
have operated on 40 pituitary tumors, only 
one of which was-done by craniotomy. There 
was a suprasellar extension that went laterally 
into one frontal lobe, and you simply cannot 
turn the corner going through the sphenoid 
sinus. Consequently, this patient was done 
transfron tally . 
3. The patient with paracentral, bitemporal 
scotomas: The neuro-ophthalmologist will 
assure you that this patient has either a pre-
fixed chiasm or a retrochiasmal nodule. 
This presents a difficult problem for the 
neurosurgeon operating transfrontally, be-
cause the optic nerves are hugging the 
tuberculum and there is no room to work 
between the optic nerves. This is, in my opi-
nion, an indication, unless there is some con-
traindication, to the transphenoidal route. 
4. The microadenoma (mentioned earlier); 
5. Spontaneous rhinorrhea in association with a 
pituitary tumor; 
6. Pituitary apoplexy: A low morbidity 
procedure accomplishes what you want to ac-
complish very quickly, and since these 
patients are often ill and need rapid decom-
pression, I think it is clearly the procedure of 
choice for pituitary apoplexy. 
7. The patient who is old or debilitated for 
whatever reason, or if you simply want to do 
a biopsy. 
Which tumors should be approached by the 
transfrontal technique? Again, this is my own preju-
dice . The massive suprasellar extension is a huge 
mass of intracranial tumor, and what is happening 
within and immediately above the sella is really not 
the important part of the tumor. I have discussed the 
tumor with lateral extension. Perhaps tumors with 
massive suprasellar and sphenoidal extensions should 
be removed sequentially by both routes. The one con-
traindication to any major procedure is unequivocal 
cavernous sinus invasion. Extraocular motor palsies 
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alone are not an indication of invasion. As pointed 
out by Sir Geoffrey Jefferson, a fixed sensory loss is 
the one clinical sign of cavernous sinus invasion . 
In summary, the one thing that is new in 
the management of pituitary tumors is the 
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transsphenoidal technique. Obviously, there still 
remains a place for transfrontal craniotomy and 
cryosurgery, but I predict that an increasing number 
of pituitary tumors will be done by the 
transsphenoidal technique. 
